| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | — | -71.7% |
| R&D Expense | $8.4M | — | +16.4% |
| SG&A Expense | $8.9M | — | -23.1% |
| Pre-tax Income | -$50.9M | — | -1.0% |
| Income Tax | -$1.6M | — | -1180.0% |
| Net Income | -$70.3M | — | -39.1% |
| EPS (Basic) | -$4.29 | — | -28.8% |
| EPS (Diluted) | -$4.29 | — | -28.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $64.3M | -35.6% | -41.9% |
| Total Assets | $1.57B | +4.2% | +56.1% |
| Total Liabilities | $1.56B | +6.3% | +40.9% |
| Stockholders' Equity | $8.6M | -77.0% | +108.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$125.2M | — | -118.9% |
| Capital Expenditures | $378K | — | +87.1% |
| Investing Cash Flow | -$11.6M | — | +92.7% |
| Financing Cash Flow | $105.2M | — | -11.4% |
| Free Cash Flow | -$125.6M | — | -118.8% |